Latest Shareholder Meetings News

London City reports a record investment portfolio value of $27.3 million, buoyed by strong gains in Fiducian Group shares, while legal proceedings against Excelsior Capital and its directors continue to unfold.

Gold Road Resources has secured a crucial regulatory green light as the Foreign Investment Review Board approves Gold Fields’ acquisition scheme. The deal now moves closer to shareholder and court approvals.

Yowie Group Ltd has firmly rejected the validity of director removal and nomination notices purportedly from Keybridge Capital, while confirming its status as Keybridge’s largest creditor with over $6.6 million owed. The company also detailed a recent share placement amid ongoing regulatory scrutiny.

Midas Minerals has locked in $6.5 million through a two-tranche placement to fund its strategic acquisition and exploration of the Otavi Copper Project in Namibia, alongside advancing its broader project portfolio.

Emu NL’s recent shareholder meeting saw all attempts to remove or elect new directors decisively rejected, reinforcing board stability as the company completes a planned capital raise.

Uvre Limited is set to acquire New Zealand gold explorer Otagold, backed by a $4 million equity raise and the appointment of mining veterans Norman Seckold and Peter Nightingale to its board.

Metals X Limited has committed $5 million to acquire a significant stake in Elementos Limited through a private placement, positioning itself as a key player in the tin development sector.

Contact Energy Limited has announced a court-approved scheme to acquire Manawa Energy Limited, offering Manawa shareholders $1.12 cash plus 0.5830 new Contact shares per share, representing a significant premium. The merger aims to create a diversified renewable energy portfolio with substantial synergies and growth prospects.

Keybridge Capital urges shareholders to take no action following an off-market takeover bid from its own subsidiary, Yowie Group, citing serious governance concerns and legal disputes.

The Reject Shop Limited has entered a recommended scheme of arrangement with Dollarama Inc., offering shareholders $6.68 cash per share, a substantial premium over recent trading prices. The Independent Expert deems the deal fair and reasonable, with a shareholder meeting set for June 23.

Mayne Pharma Group has proposed a $7.40 per share acquisition by Cosette Pharmaceuticals, with unanimous board support and a fair and reasonable opinion from an independent expert. Shareholders will vote on the scheme on June 18, 2025.

Peak Rare Earths is poised for acquisition by Shenghe Resources in a deal valuing the company at A$150.5 million, supported by a A$7.5 million entitlement offer to fund ongoing development and transaction costs.